1622977246876106753
6) Compare that to Pfizer’s six-month safety analysis, which claimed only 1.2% of trial participants experienced a serious adverse event.
— Dr. Joseph Mercola (@mercola) February 7, 2023
1622977246876106753
6) Compare that to Pfizer’s six-month safety analysis, which claimed only 1.2% of trial participants experienced a serious adverse event.
— Dr. Joseph Mercola (@mercola) February 7, 2023